Combined medicament of brain protein hydrolysate

A cerebroprotein hydrolysate and drug technology, applied in the field of cerebroprotein hydrolyzate combined medicine, can solve the problems of allergies, disorders, fever and the like

Inactive Publication Date: 2010-06-23
邓学峰
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the cerebroprotein hydrolyzate prepared by the prior art has adv

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The cerebroprotein hydrolyzate combination medicine provided by the present invention is made of the following medicinal ingredients in parts by weight:

[0019] Brain protein hydrolyzate raw material liquid medicine 2.2

[0020] Reduced Glutathione 0.015

[0021] 1 gram of cerebroprotein hydrolyzate raw drug solution is equivalent to nitrogenous substances in 1 gram of cerebroprotein.

[0022] The present invention provides the preparation method of the above-mentioned cerebroprotein hydrolyzate combination medicine:

[0023] (1). Add reduced glutathione to the cerebroprotein hydrolyzate raw material medicinal solution under stirring at 80 to 100 rpm, and dissolve completely to prepare the cerebroprotein hydrolyzate combined drug medicinal solution;

[0024] (2). The cerebroprotein hydrolyzate combination drug solution prepared in step (1) is first ultrafiltered through an ultrafiltration membrane with a molecular weight cut-off of 10000D, and the filtrate is collect...

Embodiment 2

[0029] The cerebroprotein hydrolyzate combination medicine provided by the present invention is made of the following medicinal ingredients in parts by weight:

[0030] Brain protein hydrolyzate raw material liquid medicine 33

[0031] Reduced Glutathione 0.025

[0032] 1 gram of cerebroprotein hydrolyzate raw drug solution is equivalent to nitrogenous substances in 1 gram of cerebroprotein.

[0033] The present invention provides the preparation method of the above-mentioned cerebroprotein hydrolyzate combination medicine:

[0034] (1). Add reduced glutathione to the cerebroprotein hydrolyzate raw material medicinal solution under stirring at 80 to 100 rpm, and dissolve completely to prepare the cerebroprotein hydrolyzate combined drug medicinal solution;

[0035] (2). The cerebroprotein hydrolyzate combination drug solution prepared in step (1) is first ultrafiltered through an ultrafiltration membrane with a molecular weight cut-off of 10000D, and the filtrate is collecte...

Embodiment 3

[0040] The cerebroprotein hydrolyzate combination medicine provided by the present invention is made of the following medicinal ingredients in parts by weight:

[0041] Brain protein hydrolyzate raw material liquid medicine 21

[0042] Reduced glutathione 0.019

[0043] 1 gram of cerebroprotein hydrolyzate raw drug solution is equivalent to nitrogenous substances in 1 gram of cerebroprotein.

[0044] The present invention provides the preparation method of the above-mentioned cerebroprotein hydrolyzate combination medicine:

[0045] (1). Add reduced glutathione to the cerebroprotein hydrolyzate raw material medicinal solution under stirring at 80 to 100 rpm, and dissolve completely to prepare the cerebroprotein hydrolyzate combined drug medicinal solution;

[0046] (2). The cerebroprotein hydrolyzate combination drug solution prepared in step (1) is first ultrafiltered through an ultrafiltration membrane with a molecular weight cut-off of 10000D, and the filtrate is collecte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a combined medicament of brain protein hydrolysate. The medicament is made from medical ingredients of the following shares by weight: 2.2 to 33 shares of brain protein hydrolysate raw material liquor and 0.015 to 0.025 share of reduced glutathione. Nitrogenous substances in one gram of brain protein hydrolysate raw material liquor are equivalent to those in one gram of brain protein. The combined medicament of brain protein hydrolysate largely alleviates the allergic and drug fever adverse reactions of the existing brain protein hydrolysate medicaments. The therapeutic effect is improved.

Description

technical field [0001] The invention relates to a cerebroprotein hydrolyzate combined medicine and a preparation method thereof. Background technique [0002] Cerebrolysin hydrolyzate, also known as cerebrolysin, English name: Cerebrolysin. It is an aqueous solution of a protein-free mixture of specific amino acids extracted from calf brain. It contains various essential amino acids and non-essential amino acids, as well as glutamine, asparagine, ornithine, water citrulline, γ-aminobutyric acid and γ-aminoβ-hydroxybutyric acid, etc. and low-molecular-weight polypeptides. This product has the protective function against hypoxia of brain nerve cells, can activate adenylyl cyclase, catalyze the hormone system, and improve memory. However, the cerebroprotein hydrolyzate prepared by the prior art has adverse reactions such as allergy, fever, or chills, and renal dysfunction. Contents of the invention [0003] In order to overcome the defects of cerebroprotein hydrolyzate pre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/06A61K38/01A61P25/00
Inventor 邓学峰蔡海德
Owner 邓学峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap